PAIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.999600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.747200E-01
Normal-vs-Stage2
9.980000E-01
Normal-vs-Stage3
5.011000E-01
Normal-vs-Stage4
6.968200E-01
Stage1-vs-Stage2
5.884800E-01
Stage1-vs-Stage3
4.337200E-01
Stage1-vs-Stage4
4.073400E-01
Stage2-vs-Stage3
3.179000E-01
Stage2-vs-Stage4
4.674800E-01
Stage3-vs-Stage4
2.487800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.699000E-01
Normal-vs-AfricanAmerican
7.798800E-01
Normal-vs-Asian
9.137800E-01
Caucasian-vs-AfricanAmerican
5.696600E-01
Caucasian-vs-Asian
7.464000E-01
AfricanAmerican-vs-Asian
8.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.913000E-01
Normal-vs-Female
9.059800E-01
Male-vs-Female
3.465800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.297200E-01
Normal-vs-Age(41-60Yrs)
6.469400E-01
Normal-vs-Age(61-80Yrs)
7.828600E-01
Normal-vs-Age(81-100Yrs)
6.331200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.876400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.612000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.440400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.169780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.048400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.324400E-01
Normal-vs-Daily Drinker
7.292600E-01
Normal-vs-Weekly Drinker
7.658800E-01
Normal-vs-Occasional Drinker
6.459800E-01
Normal-vs-Social Drinker
8.137600E-01
Non Drinker-vs-Daily Drinker
9.162200E-01
Non Drinker-vs-Weekly Drinker
3.115400E-01
Non Drinker-vs-Occasional Drinker
4.422400E-02
Non Drinker-vs-Social Drinker
1.467430E-01
Daily Drinker-vs-Weekly Drinker
3.414200E-01
Daily Drinker-vs-Occasional Drinker
1.116750E-01
Daily Drinker-vs-Social Drinker
2.619800E-01
Weekly Drinker-vs-Occasional Drinker
7.949600E-01
Weekly Drinker-vs-Social Drinker
6.659600E-01
Occasional Drinker-vs-Social Drinker
6.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.801400E-01
Normal-vs-Grade 2
6.893800E-01
Normal-vs-Grade 3
7.127600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.242400E-01
Grade 1-vs-Grade 3
1.067840E-01
Grade 1-vs-Grade 4
6.801400E-01
Grade 2-vs-Grade 3
6.665600E-02
Grade 2-vs-Grade 4
6.893800E-01
Grade 3-vs-Grade 4
7.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.070200E-01
Normal-vs-NonDiabetic
9.271200E-01
Diabetic-vs-NonDiabetic
6.060000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.352800E-01
Normal-vs-NoPancreatitis
9.978000E-01
Pancreatitis-vs-NoPancreatitis
7.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.830200E-01
Normal-vs-N1
9.805200E-01
N0-vs-N1
9.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.919200E-01
Normal-vs-TP53-NonMutant
6.851400E-01
TP53-Mutant-vs-TP53-NonMutant
1.844500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
